CANCER AND LEUKEMIA GROUP B

描述（改编自申请人的摘要）：本资助申请 提交支持CALGB计划在医科大学 南卡罗来纳州（MUSC）。 MUSC自7月以来一直是CALGB的主要成员 1995. 然而，已经是集团副主席，副主席的CALGB 放射肿瘤学委员会，CALGB呼吸委员会主席， 一个第三阶段协议主席，和四个研究共同主席是MUSC教师 参与者 活跃的MUSC程序在实验治疗学，分子 肿瘤学和癌症预防和控制参与研究 对基于CALGB的临床和相关活动具有直接意义 在本报告所涵盖的赠款周期内向小组提出的项目 应用程序. CALGB试验的应计费用已被指定为 癌症中心主任优先考虑的机构临床试验 MUSC。 一个新的CALGB附属关系的拉尔夫H。弗吉尼亚州约翰逊 查尔斯顿的医疗中心从1997年夏天开始开发。 这将大大有助于增加机构应计负债。 MUSC的少数族裔应计费用一直是CALGB平均水平的两倍多。 它的范围从1993年的25%（当时MUSC参加了 1995年，CALGB作为鲍曼·格雷的附属公司）上升到36%。 MUSC计划 参与NCI少数应计项目，作为 CALGB主席的中央办公室拨款 该倡议计划和 MUSC的霍林斯癌症中心和查尔斯顿之间的新项目 少数民族社区，在本申请中所描述的，应促进额外的 少数应计权益 1996年9月在MUSC进行的CALGB审计被评为 好极了 南卡罗来纳州医科大学是一个有效的新的 癌症和白血病组B的主要成员，处于强势地位 做出重要的科学，行政和应计贡献， 本集团于本补助金申请所涵盖的五年期内的所有开支。

DESCRIPTION (adapted from the applicant's abstract): This grant application is submitted in support of the CALGB program at the Medical University of South Carolina (MUSC). MUSC has been a main member of CALGB only since July 1995. Yet already the Group Vice Chair, the Vice Chair of the CALGB Radiation Oncology Committee, the Chair of the CALGB Respiratory Committee, one phase III protocol chair, and four study co-chairs are MUSC faculty participants. Active MUSC programs in Experimental Therapeutics, Molecular Oncology, and Cancer Prevention and Control are involved in research activities of direct significance for CALGB based clinical and correlative projects to be proposed to the Group during the grant cycle covered by this application. Accrual to CALGB trials has been designated as the top institutional clinical trials priority by the Cancer Center Director at MUSC. A new CALGB affiliate relationship for the Ralph H. Johnson VA Medical Center in Charleston is being developed as of the Summer of 1997. This will contribute substantially to increased institutional accrual. Minority accrual at MUSC has always been more than double the CALGB average. It has ranged from a low of 25 percent in 1993 (when MUSC participated in CALGB as a Bowman Gray affiliate) to 36 percent in 1995. MUSC plans to participate in the NCI Minority accrual Initiative Program submitted as part of the CALGB Chairman's Central Office Grant. This initiative program and new programs between the Hollings Cancer Center at MUSC and the Charleston minority community, described in this application, should foster additional minority accrual. A CALGB audit at MUSC in September of 1996 was rated as excellent. The Medical University of South Carolina is an effective new Main Member in the Cancer and Leukemia Group B that is in a strong position to make important scientific, administrative, and accrual contribution to the Group during the five year period covered by this grant request.